Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vetlig is a veterinary medical device company specializing in advanced soft tissue augmentation and ligament reconstruction for companion animals. The company's flagship product is a synthetic ligament system designed to treat cranial cruciate ligament (CCL) ruptures in dogs, providing an alternative to traditional osteotomy procedures like TPLO. By utilizing high-strength synthetic fibers, Vetlig's technology allows for immediate joint stabilization and promotes long-term tissue ingrowth. The company focuses on providing minimally invasive surgical solutions that reduce recovery time and improve orthopedic outcomes for veterinary patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vetlig.